Skip to content
OpenCapital
Get started

ResMed RMD Free cash flow

Free cash flow at other companies

Eli Lilly logo
Eli LillyLLY
$3.01B+1,828%
Inogen logo
InogenINGN
-$6.9M+59.6%
Five Point Holdings, Inc. logo
Five Point Holdings, Inc.FPH
-$44.5M-179%
Inspire Medical Systems logo
Inspire Medical SystemsINSP
$3.12M+121%
Viemed Healthcare, Inc. logo
Viemed Healthcare, Inc.VMD
$1.36M+111%
LivaNova logo
LivaNovaLIVN
$926K-93.0%

Other financials

Income statement

See full
Revenue$1.4B+10.8%
Gross profit$891.0M+16.3%
Operating income$499.8M+17.3%
Net income$398.7M+9.2%
EPS (diluted)$2.74+10.5%

Balance sheet

See full
Cash & equivalents$1.7B+78.0%
Total debt$1.1B+29.8%
Total equity$6.5B+17.1%
Total assets$8.8B+16.1%

Cash flow

See full
Operating cash flow$554.1M-4.2%
CapEx$33.7M+61.8%

Valuation

See full
Market cap$28.27B-19.1%
Enterprise value$27.71B-19.8%
P/E18.6×-6.3×
P/S5.1×-1.7×

Profitability

See full
Gross margin61.6%+2.8pp
Operating margin34.2%+2.1pp
Net margin27.4%+1.3pp
FCF margin31.7%+0.4pp

Returns & leverage

See full
Return on equity25.2%-0.6pp
Debt / equity0.2×0.0×
Current ratio3×-0.4×

Where this comes from

Calculated from ResMed’s reported figures.

$554.1Mnet cash from operating−$33.7Mcapital expenditures=$520.48M

The official record: ResMed’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about ResMed's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ResMed's free cash flow?
ResMed (RMD) reported free cash flow of $520.48M in Q1 2026.
How has ResMed's free cash flow changed year-over-year?
ResMed's free cash flow decreased by 6.7% year-over-year, from $557.87M to $520.48M.
What is the long-term trend for ResMed's free cash flow?
Over 3 years (2022 to 2025), ResMed's free cash flow has grown at a 97.3% compound annual growth rate (CAGR), from $216.31M to $1.66B.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.